VEGF-C

Our opinion piece in Science Signaling was published. It discusses the results by Kataru et al., and how they relate to the continuing (re)search for a lymphedema drug after the discontinuation of the clinical trials with Lymfactin.

Vascular endothelial growth factor-C (VEGF-C) has been originally described as the primary growth factor for the lymphatic system.

My first Ph.D. mentee successfully defended his thesis on the topic Mechanism of VEGF-C Activation and Effect on Lymphatic Growth and Regeneration.